REPLIGEN CORP: RGEN (Nasdaq Global Market)
Enter your Email for a Free Trial: 
Free Trial
Form (Filer)  Received ( Period
4 REPLIGEN CORP(COOPER GLENN L MD  11/17/09 (11/09/09) 
SC 13G REPLIGEN CORP(FEDERATED INVESTORS INC /PA/  11/10/09 
10-Q REPLIGEN CORP  11/05/09 (09/30/09) 
8-K REPLIGEN CORP  11/05/09 (11/05/09) 
4 REPLIGEN CORP(COOPER GLENN L MD  08/25/09 (08/24/09) 
3 REPLIGEN CORP(COOPER GLENN L MD  08/25/09 (08/25/09) 
8-K REPLIGEN CORP  08/25/09 (08/24/09) 
10-Q REPLIGEN CORP  08/06/09 (06/30/09) 
8-K REPLIGEN CORP  08/06/09 (08/06/09) 
DEF 14A REPLIGEN CORP  07/28/09 (09/11/09) 
4 REPLIGEN CORP(BIOTECHNOLOGY VALUE FUND L P  07/08/09 (07/06/09) 
10-K REPLIGEN CORP  06/11/09 (03/31/09) 
8-K REPLIGEN CORP  06/11/09 (06/11/09) 
3 REPLIGEN CORP(BIOTECHNOLOGY VALUE FUND L P  05/20/09 (05/15/09) 
SC 13G/A REPLIGEN CORP(BIOTECHNOLOGY VALUE FUND L P  05/20/09 
4 REPLIGEN CORP(RYAN THOMAS F JR  04/30/09 (09/12/08) 
4 REPLIGEN CORP(GOLDBERG ALFRED LEWIS  04/30/09 (09/12/08) 
4 REPLIGEN CORP(HENRY EARL WEBB  04/30/09 (09/12/08) 
4 REPLIGEN CORP(DAWES KAREN A  04/30/09 (09/12/08) 
SC 13G REPLIGEN CORP(WINSLOW MANAGEMENT COMPANY, LLC  02/17/09 
 
 Results 1 - 20 of 352
     [1] 2 3 4 5 6 7 8 9 10   Next 8 Pages [ Show Next 20 Results ] 
Last Trade
Last Trade: 
$4.76  
Change: 
0.04 (0.85%)  
Trade Time: 
Nov 20  
Market Cap: 
$146.41M
Company People
View Officers and Directors and Other Key Individuals Mentioned in REPLIGEN CORP SEC Filings

Premium Content from Alacrastore.com